147 related articles for article (PubMed ID: 11061612)
1. Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction.
Sandler AB; Kindler HL; Einhorn LH; Mitchell E; Masters G; Kraut M; Nicol S; Raghavan D
Ann Oncol; 2000 Sep; 11(9):1161-4. PubMed ID: 11061612
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma.
Morgan-Meadows S; Mulkerin D; Berlin JD; Kim K; Bailey H; Saphner T; Jumonville A; Hansen R; Ahuja H; McFarland T; Thomas JP
Oncology; 2005; 69(2):130-4. PubMed ID: 16118509
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial.
Williamson SK; McCoy SA; Gandara DR; Dakhil SR; Yost KJ; Paradelo JC; Atkins JN; Blanke CD; Abbruzzese JL;
Am J Clin Oncol; 2006 Apr; 29(2):116-22. PubMed ID: 16601427
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study.
Urba SG; Chansky K; VanVeldhuizen PJ; Pluenneke RE; Benedetti JK; Macdonald JS; Abbruzzese JL;
Invest New Drugs; 2004 Jan; 22(1):91-7. PubMed ID: 14707499
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Catimel G; Vermorken JB; Clavel M; de Mulder P; Judson I; Sessa C; Piccart M; Bruntsch U; Verweij J; Wanders J
Ann Oncol; 1994 Jul; 5(6):543-7. PubMed ID: 7918127
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study.
Zatloukal P; Kanitz E; Magyar P; Jassem J; Krzakowski M; Pawlicki M; Petruzelka L; Chovan L; Pesek M; Janko C; Krejcy K
Lung Cancer; 1998 Dec; 22(3):243-50. PubMed ID: 10048477
[TBL] [Abstract][Full Text] [Related]
7. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
[TBL] [Abstract][Full Text] [Related]
10. Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma.
Lee MY; Jung KS; Kim HS; Lee JY; Lim SH; Kim M; Jung HA; Kim SM; Sun JM; Ahn MJ; Lee J; Park SH; Yi SY; Hwang IG; Lee SC; Ahn HK; Lim DH; Lee SI; Park KW
World J Gastroenterol; 2015 Apr; 21(14):4268-74. PubMed ID: 25892878
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms.
Levitt ML; Kassem B; Gooding WE; Miketic LM; Landreneau RJ; Ferson PF; Keenan R; Yousem SA; Lindberg CA; Trenn MR; Ponas RS; Tarasoff P; Sabatine JM; Friberg D; Whiteside TL
Lung Cancer; 2004 Mar; 43(3):335-44. PubMed ID: 15165093
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients.
Lund B; Hansen OP; Theilade K; Hansen M; Neijt JP
J Natl Cancer Inst; 1994 Oct; 86(20):1530-3. PubMed ID: 7932808
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer.
Kroep JR; Pinedo HM; Giaccone G; Van Bochove A; Peters GJ; Van Groeningen CJ
Ann Oncol; 2004 Feb; 15(2):230-5. PubMed ID: 14760114
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group.
Jatoi A; Murphy BR; Foster NR; Nikcevich DA; Alberts SR; Knost JA; Fitch TR; Rowland KM;
Ann Oncol; 2006 Jan; 17(1):29-34. PubMed ID: 16303863
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of gemcitabine in patients with advanced gastric cancer.
Christman K; Kelsen D; Saltz L; Tarassoff PG
Cancer; 1994 Jan; 73(1):5-7. PubMed ID: 8275437
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
Belani CP; Dakhil S; Waterhouse DM; Desch CE; Rooney DK; Clark RH; Monberg MJ; Ye Z; Obasaju CK
Ann Oncol; 2007 Jan; 18(1):110-115. PubMed ID: 17043094
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of gemcitabine in advanced colorectal adenocarcinoma.
Moore DF; Pazdur R; Daugherty K; Tarassoff P; Abbruzzese JL
Invest New Drugs; 1992 Nov; 10(4):323-5. PubMed ID: 1487408
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial.
Huang J; Fan QX; Chen L; Liu AN; Cai RG; Hao XZ; Wang JW; Sun Y
Chin Med J (Engl); 2011 Dec; 124(23):4012-7. PubMed ID: 22340334
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Calvert SW; Willcutt NT; Scullin DC; Bramham J; Greco FA
Cancer Invest; 2001; 19(4):335-9. PubMed ID: 11405172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
